Administrative and Clinical Services Core

行政和临床服务核心

基本信息

  • 批准号:
    10449386
  • 负责人:
  • 金额:
    $ 20.45万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2007
  • 资助国家:
    美国
  • 起止时间:
    2007-07-01 至 2024-07-31
  • 项目状态:
    已结题

项目摘要

The Director of the Administrative and Clinical Services (ACS) Core will be Dr. Susan Chang and the Associate Director will be Dr. Jennifer Clarke. The Administrative component will be led by Dr. Chang and the Clinical component will be led by Dr. Clarke. Dr. Sarah Nelson and Dr. Daniel Vigneron will serve as co-investigators in order to provide oversight of the technical aspects of the Projects planned. Dr. Chang is the Director of the Division of Neuro-Oncology and is the overall PI of the PI and was as well as the director of the Administrative Core of the prior PPG. She is experienced in the coordination of multiple projects and cores and has effectively provided the leadership for the successful activities of the previous cycle. She has demonstrated clear commitment to providing oversight of the PPG. The specific aims of the ACS Core are to provide Administrative and Clinical services to all our Projects to accomplish their Specific Aims and Research Plans. Administrative support will include fiscal, grants management and clerical support for annual progress reports and manuscript preparation, and organization for meetings between the key personnel from the projects and cores, as well as for meetings with the External Advisory Board. Two of the Projects will involve patient research studies and the clinical component will provide the infrastructure and personnel to allow the conduct of non-therapeutic and therapeutic research studies. This will include clinical scientists, neurosurgeons, research nurses and clinical research assistants, as well as clinical space to obtain informed consent, treat, and follow patients enrolled in clinical studies within all the Projects. The overall goal of the ACS Core will be to facilitate the interactions of the members of this P01, provide clinical research support for the Projects, and administratively coordinate activities of the P01investigators. The following table depicts the distribution of effort provided to the four Projects by the two components of the ACS Core. Component Project 1 Project 2 Project 3 Project 4 Total Administrative 25% 25% 25% 25% 100% Clinical 60% 0% 0% 40% 100%
行政和临床服务(ACS)中心主任将由Susan Chang博士和助理 主任是詹妮弗·克拉克博士行政部门将由Chang博士和临床 将由克拉克博士领导。Sarah纳尔逊博士和丹尼尔Vigneron博士将担任共同研究者, 以便对计划项目的技术方面进行监督。张博士是 神经肿瘤科,是PI的总PI,曾担任行政主管 先前PPG的核心。她在协调多个项目和核心方面经验丰富, 为上一个周期的成功活动提供了领导。她清楚地表明, 承诺对PPG进行监督。ACS核心的具体目标是提供 为我们所有的项目提供临床服务,以实现其特定目标和研究计划。行政 支助将包括财政、赠款管理和为年度进展报告和手稿提供文书支助 准备和组织项目和核心的关键人员之间的会议,以及 与外部咨询委员会举行会议。其中两个项目将涉及病人研究和 临床部分将提供基础设施和人员,以允许进行非治疗性和 治疗研究。这将包括临床科学家,神经外科医生,研究护士和临床 研究助理,以及临床空间,以获得知情同意,治疗和随访入组的患者 所有项目中的临床研究。ACS核心的总体目标是促进 本P01的成员,为项目提供临床研究支持,并在行政上协调活动 P01调查员下表说明了联合国各机构为这四个项目所作努力的分布情况。 ACS核心的两个组成部分 组成项目1项目2项目3项目4合计 行政25% 25% 25% 25% 100% 临床60% 0% 0% 40% 100%

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Susan M Chang其他文献

The oncological role of resection in newly diagnosed diffuse adult-type glioma defined by the WHO 2021 classification: a Review by the RANO resect group
世界卫生组织 2021 年分类所定义的新诊断成人弥漫性胶质瘤切除的肿瘤学作用:RANO 切除组的综述
  • DOI:
    10.1016/s1470-2045(24)00130-x
  • 发表时间:
    2024-09-01
  • 期刊:
  • 影响因子:
    35.900
  • 作者:
    Philipp Karschnia;Jasper K W Gerritsen;Nico Teske;Daniel P Cahill;Asgeir S Jakola;Martin van den Bent;Michael Weller;Oliver Schnell;Einar O Vik-Mo;Niklas Thon;Arnaud J P E Vincent;Michelle M Kim;Guido Reifenberger;Susan M Chang;Shawn L Hervey-Jumper;Mitchel S Berger;Joerg-Christian Tonn
  • 通讯作者:
    Joerg-Christian Tonn
Consensus on the Role of Human Cytomegalovirus in Glioblastoma Neuro-onco Lo Gy
人类巨细胞病毒在胶质母细胞瘤神经肿瘤中的作用共识
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
    K. Dziurzynski;Susan M Chang;A. Heimberger;R. Kalejta;Stuart R Mcgregor;Dallas;Martine Smit;L. Soroceanu;C. Cobbs;Gliomas Symposium;Wisconsin Madison
  • 通讯作者:
    Wisconsin Madison
PET-based response assessment criteria for diffuse gliomas (PET RANO 1.0): a report of the RANO group.
基于 PET 的弥漫性胶质瘤反应评估标准 (PET RANO 1.0):RANO 小组的报告。
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    N. Albert;N. Galldiks;B. Ellingson;M. J. van den Bent;Susan M Chang;F. Cicone;J. de Groot;E. Koh;Ian Law;E. Le Rhun;M. Mair;Giuseppe Minniti;R. Rudà;A. M. Scott;Susan C Short;M. Smits;B. Suchorska;N. Tolboom;Tatjana Traub;Joerg;Antoine Verger;M. Weller;Patrick Y Wen;M. Preusser
  • 通讯作者:
    M. Preusser

Susan M Chang的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Susan M Chang', 18)}}的其他基金

Quantitative Steady-State and Dynamic Metabolic MRI for Evaluating Patients with Glioma
用于评估神经胶质瘤患者的定量稳态和动态代谢 MRI
  • 批准号:
    10588189
  • 财政年份:
    2022
  • 资助金额:
    $ 20.45万
  • 项目类别:
Quantitative Steady-State and Dynamic Metabolic MRI for Evaluating Patients with Glioma
用于评估神经胶质瘤患者的定量稳态和动态代谢 MRI
  • 批准号:
    10444826
  • 财政年份:
    2022
  • 资助金额:
    $ 20.45万
  • 项目类别:
NOVEL BIOMARKERS OF MALIGNANT PROGRESSION IN RECURRENT LOW GRADE GLIOMA
复发性低级别胶质瘤恶性进展的新型生物标志物
  • 批准号:
    8514310
  • 财政年份:
    2013
  • 资助金额:
    $ 20.45万
  • 项目类别:
Imaging and Tissue Correlates to Optimize Management of Glioblastoma
影像学和组织相关性可优化胶质母细胞瘤的治疗
  • 批准号:
    8721854
  • 财政年份:
    2007
  • 资助金额:
    $ 20.45万
  • 项目类别:
Biospecimen and Biostatistics Core
生物样本和生物统计学核心
  • 批准号:
    9317443
  • 财政年份:
    2007
  • 资助金额:
    $ 20.45万
  • 项目类别:
Imaging Core
成像核心
  • 批准号:
    8738075
  • 财政年份:
    2007
  • 资助金额:
    $ 20.45万
  • 项目类别:
Noninvasive Metabolic Signatures to Improve Management of Molecular Subtypes of Glioma
无创代谢特征可改善神经胶质瘤分子亚型的管理
  • 批准号:
    9790509
  • 财政年份:
    2007
  • 资助金额:
    $ 20.45万
  • 项目类别:
Imaging and Tissue Correlates to Optimize Management of Glioblastoma
影像学和组织相关性可优化胶质母细胞瘤的治疗
  • 批准号:
    9114035
  • 财政年份:
    2007
  • 资助金额:
    $ 20.45万
  • 项目类别:
Diversity Supplement: 5P01CA118816 Project 1
多样性补充:5P01CA118816 项目 1
  • 批准号:
    10381390
  • 财政年份:
    2007
  • 资助金额:
    $ 20.45万
  • 项目类别:
Admin-Core-001
管理核心-001
  • 批准号:
    10495861
  • 财政年份:
    2007
  • 资助金额:
    $ 20.45万
  • 项目类别:

相似海外基金

MRI and Biological Markers of Acute E-Cigarette Exposure in Smokers and Vapers
吸烟者和电子烟使用者急性电子烟暴露的 MRI 和生物标志物
  • 批准号:
    10490338
  • 财政年份:
    2021
  • 资助金额:
    $ 20.45万
  • 项目类别:
MRI and Biological Markers of Acute E-Cigarette Exposure in Smokers and Vapers
吸烟者和电子烟使用者急性电子烟暴露的 MRI 和生物标志物
  • 批准号:
    10353104
  • 财政年份:
    2021
  • 资助金额:
    $ 20.45万
  • 项目类别:
Investigating pollution dynamics of swimming pool waters by means of chemical and biological markers
利用化学和生物标记物研究游泳池水体的污染动态
  • 批准号:
    21K04320
  • 财政年份:
    2021
  • 资助金额:
    $ 20.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
MRI and Biological Markers of Acute E-Cigarette Exposure in Smokers and Vapers
吸烟者和电子烟使用者急性电子烟暴露的 MRI 和生物标志物
  • 批准号:
    10688286
  • 财政年份:
    2021
  • 资助金额:
    $ 20.45万
  • 项目类别:
Novel biological markers for immunotherapy and comprehensive genetic analysis in thymic carcinoma
用于胸腺癌免疫治疗和综合遗传分析的新型生物标志物
  • 批准号:
    20K17755
  • 财政年份:
    2020
  • 资助金额:
    $ 20.45万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Examination of Biological Markers Associated with Neurobehavioral and Neuropsychological Outcomes in Military Veterans with a History of Traumatic Brain Injury
与有脑外伤史的退伍军人的神经行为和神经心理结果相关的生物标志物的检查
  • 批准号:
    10578649
  • 财政年份:
    2019
  • 资助金额:
    $ 20.45万
  • 项目类别:
Examination of Biological Markers Associated with Neurobehavioral and Neuropsychological Outcomes in Military Veterans with a History of Traumatic Brain Injury
与有脑外伤史的退伍军人的神经行为和神经心理结果相关的生物标志物的检查
  • 批准号:
    10295141
  • 财政年份:
    2019
  • 资助金额:
    $ 20.45万
  • 项目类别:
Examination of Biological Markers Associated with Neurobehavioral and Neuropsychological Outcomes in Military Veterans with a History of Traumatic Brain Injury
与有脑外伤史的退伍军人的神经行为和神经心理结果相关的生物标志物的检查
  • 批准号:
    10041708
  • 财政年份:
    2019
  • 资助金额:
    $ 20.45万
  • 项目类别:
Examination of Biological Markers Associated with Neurobehavioral and Neuropsychological Outcomes in Military Veterans with a History of Traumatic Brain Injury
与有脑外伤史的退伍军人的神经行为和神经心理结果相关的生物标志物的检查
  • 批准号:
    9776149
  • 财政年份:
    2019
  • 资助金额:
    $ 20.45万
  • 项目类别:
Combining biological and non-biological markers to develop a model predictive of treatment response for individuals with depression
结合生物和非生物标志物来开发预测抑郁症患者治疗反应的模型
  • 批准号:
    2063934
  • 财政年份:
    2018
  • 资助金额:
    $ 20.45万
  • 项目类别:
    Studentship
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了